172 related articles for article (PubMed ID: 35745191)
1. Link between Omega 3 Fatty Acids Carried by Lipoproteins and Breast Cancer Severity.
Bobin-Dubigeon C; Nazih H; Croyal M; Bard JM
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745191
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients.
Peña-de-la-Sancha P; Muñoz-García A; Espínola-Zavaleta N; Bautista-Pérez R; Mejía AM; Luna-Luna M; López-Olmos V; Rodríguez-Pérez JM; Fragoso JM; Carreón-Torres E; Pérez-Méndez Ó
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982461
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
4. The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans.
Nelson GJ; Schmidt PC; Bartolini GL; Kelley DS; Kyle D
Lipids; 1997 Nov; 32(11):1137-46. PubMed ID: 9397398
[TBL] [Abstract][Full Text] [Related]
5. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
8. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
[TBL] [Abstract][Full Text] [Related]
9. Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation.
So J; Asztalos BF; Horvath K; Lamon-Fava S
J Clin Lipidol; 2022; 16(6):887-894. PubMed ID: 36522805
[TBL] [Abstract][Full Text] [Related]
10. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
Jacobson TA; Glickstein SB; Rowe JD; Soni PN
J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans.
Bønaa KH; Bjerve KS; Nordøy A
Arterioscler Thromb; 1992 Jun; 12(6):675-81. PubMed ID: 1534256
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279
[TBL] [Abstract][Full Text] [Related]
13. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
Buckley R; Shewring B; Turner R; Yaqoob P; Minihane AM
Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651
[TBL] [Abstract][Full Text] [Related]
14. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
15. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
Sherratt SCR; Juliano RA; Mason RP
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183254. PubMed ID: 32135144
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid.
Sherratt SCR; Mason RP
Biochem Biophys Res Commun; 2018 Feb; 496(2):335-338. PubMed ID: 29331380
[TBL] [Abstract][Full Text] [Related]
18. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
[TBL] [Abstract][Full Text] [Related]
19. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
Skulas-Ray AC; Alaupovic P; Kris-Etherton PM; West SG
J Clin Lipidol; 2015; 9(3):360-7. PubMed ID: 26073395
[TBL] [Abstract][Full Text] [Related]
20. Interaction between
Emam M; Katan T; Caballero-Solares A; Taylor RG; Parrish KS; Rise ML; Parrish CC
Philos Trans R Soc Lond B Biol Sci; 2020 Aug; 375(1804):20190648. PubMed ID: 32536300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
